CAPCO Programs

Branford’s New Haven Pharmaceuticals, a CAPCO Program company, has raised more money:

Branford’s New Haven Pharmaceuticals has raised $1.6 million from several investors, including Connecticut Innovations, which announced the deal.

The company will use the funds to help it advance its first drug product, Durlaza, which is meant to be a secondary prevention for strokes and acute cardiovascular events.

Read more »

Advantage Capital Partners has selected Ironwood Capital to identify potential companies for investments:

Connecticut has chosen a Missouri-based equity and venture capital firm to manage a $72 million investment pool aimed at growing small businesses.

The new funds come out of a provision in the recently passed jobs bill, which revised the state’s Insurance Reinvestment Tax Credit program to allow money managers to invest in any Connecticut-based business, not only insurance-related ones.

Read more »